Dr. Haldar, Sunanda
( 12+ Yrs graduation )
Share this profile
|
Oncology |
|
Maharashtra, Maharashtra |
|
West Bengal Medical Council |
|
Medical Registration Verified |
Reviews & Ratings
Start Your Review
Also Listed in
Chemotherapy
Radiation therapy
Immunotherapy
More Details About Doctor
Dr. Haldar, Sunanda is a seasoned in Oncology with over 12 years of experience, based in Maharashtra. Known for their compassionate approach and commitment to patient education, Dr. Haldar, Sunanda ensures that each patient understands their condition and treatment options. Whether managing chronic illnesses or offering preventive care, Dr. Haldar, Sunanda combines expertise with the latest medical advancements to deliver optimal health outcomes.
Contact
|
|
|
|
|
|
Recommended Oncologists
Recommended Doctors in Maharashtra
Related Articles
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
11th September | 2023
Sarclisa is a promising new drug that has the potential to revolutionize the way we treat cancer.
Read More
Harnessing the Power of Artificial Intelligence: Transforming Cancer Research and Treatment with Deep Learning
8th October | 2024
Explore how artificial intelligence and deep learning are revolutionizing cancer research and treatment for precision medicine and better outcomes.
Read More
Decoding Hamartomas: Understanding Their Causes and Symptoms
10th March | 2023
A hamartoma is a growth of tissue that resembles a tumor, but is composed of normal cells.
Read More
The Benefits and Side Effects of Bortezomib in the Fight Against Cancer
13th June | 2023
Bortezomib is a type of medication known as a proteasome inhibitor that has been widely used in the fight against cancer.
Read More
Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer
15th October | 2024
Explore a pioneering case series highlighting the role of immunotherapy in treating microsatellite instability-high colorectal cancer.
Read More
